L. Culpi

Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial

Rheumatoid arthritis: pathogenesis and therapeutic advances

Incidence of cystic fibrosis in five different states of Brazil as determined by screening of p.F508del, mutation at the CFTR gene in newborns and patients

Diversity of the MBL2 Gene in Various Brazilian Populations and the Case of Selection at the Mannose-Binding Lectin Locus